About NBR“Nightly Business Report produced by CNBC” (NBR) is an award-winning and highly-respected nightly business news program that airs on public television. Television’s longest-running evening business news broadcast, “NBR” features in-depth coverage and analysis of the biggest financial news stories of the day and access to some of the world’s top business leaders and policy makers.
- FCC Chairman Ajit Pai will step down on January 20
- DoorDash seeks valuation of up to $32 billion in IPO, double what it was in June
- Elon Musk says SpaceX's next Starship test flight may happen as early as Wednesday
- Wall Street sell-off picks up steam, Dow falls 400 points to cut into November's big gain
- Nikola shares crater by more than 20% after GM gives up equity stake in smaller, reworked deal
NBR on TwitterMy Tweets
Subscribe to RSS
Berkeley Lovelace Jr.’s Posts
The House Judiciary Committee approved a bill Wednesday that legalizes marijuana on the federal level, removing it from Schedule 1 of the Controlled Substances Act.
The Trump administration released a plan Friday that will force hospitals and insurers to disclose their negotiate rates or risk being fined.
The CDC has dispatched more than 100 physicians and investigators to find the precise cause of the deadly outbreak.
CVS Health President and CEO Larry Merlo said Wednesday that he worries about the rise in teen tobacco use amid the popularity of vaping products such as e-cigarettes.
Wealthy Americans stand to gain from Obamacare’s demise.
The rich will likely receive billions in tax cuts if the health-care law is overturned, according to a new analysis published Monday from the Center on Budget and Policy Priorities, a Washington think tank.
A deadly lung illness linked to vaping has taken the lives of 34 people across 24 states as public health officials and regulators struggle to identify a precise cause of the outbreak, the Centers for Disease Control and Prevention said.
The House Ways and Means Committee late Tuesday approved Speaker Nancy Pelosi’s drug pricing bill, sending the legislation to the full House floor for a vote expected before the end of this month.
Biogen CEO Michel Vounatsos told CNBC on Wednesday that he is “reasonably confident” the U.S. Food and Drug Administration will approve the drugmaker’s experimental Alzheimer’s drug.
Johnson & Johnson on Tuesday reported third-quarter earnings and revenue that beat expectations, boosted by higher sales of cancer and other prescription drugs, despite multimillion-dollar legal problems from talc and opioids.
House Speaker Nancy Pelosi’s bill to lower prescription drug prices would save Medicare $345 billion over 10 years, according to a preliminary analysis from the nonpartisan Congressional Budget Office.
The acting head of the Food and Drug Administration inspected two international mail centers this week to examine U.S. efforts to seize foreign shipments of illicit vaping products, fentanyl and other drugs, the agency said Tuesday.
President Donald Trump is expected to issue an executive order Thursday making changes to the Medicare program to “protect” Americans from Democratic health-care proposals senior administration officials say would “destroy” coverage for seniors.
The Food and Drug Administration issued a warning to consumers about potentially serious cybersecurity flaws in some medical devices that could allow hackers to take control of them remotely.
Congress grilled CDC and FDA officials over two days of hearings on the vaping illness this week.
An outbreak of a mysterious lung disease worsened over the last week with 805 confirmed or probable cases, a 52% surge over the previous week, the Centers for Disease Control and Prevention said Thursday.